The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial.

KLEIN, K; MCCLURE EM; COLACI D; THORSTEN VR; HIBBERD P; ESAMAI F; GARCES A; PATEL A; SALEEM S; PASHA O; CHOMBA E; CARLO WA; KREBS NF; GOUDAR S; DERMAN RJ; LIECHTY EA; KOSO-THOMAS M; BUEKENS P; BELIZÁN JM; GOLDENBERG RL; ALTHABE F

Reproductive Health

BIOMED CENTRAL LTD

Año: 2016

1742-4755

BACKGROUND:The Antenatal Corticosteroid Trial (ACT) assessed the feasibility, effectiveness, and safety of a multifaceted intervention to increase the use of antenatal corticosteroids (ACS) in mothers at risk of preterm birth at all levels of care in low and middle-income countries. The intervention effectively increased the use of ACS but had no overall impact on neonatal mortality in the targeted